Evidence map›Paper›PMID 42028298›Full record

ArticleBiophotonics discovery2025

Investigating machine learning algorithms to classify label-free images of pancreatic neuroendocrine neoplasms.

Noelle Daigle, Shuyuan Guan, Suzann Duan, Thomas G Knapp, Eung-Joo Lee, Ali Azhdarinia, Sukhen C Ghosh, Solmaz AghaAmiri, Servando Hernandez Vargas, Naruhiko Ikoma and 6 more

Abstract read
In one paragraph

Article in Biophotonics discovery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Noelle DaigleUniversity of Arizona, Wyant College of Optical Sciences, Tucson, Arizona, United States.ORCID https://orcid.org/0009-0008-5941-8264
Shuyuan GuanUniversity of Arizona, Wyant College of Optical Sciences, Tucson, Arizona, United States.ORCID https://orcid.org/0009-0008-7514-7601
Suzann DuanUniversity of California, Irvine, Department of Pharmaceutical Sciences, Irvine, Arizona, United States.ORCID https://orcid.org/0000-0002-5129-0736
Thomas G KnappUniversity of Arizona, Department of Biomedical Engineering, Tucson, Arizona, United States.ORCID https://orcid.org/0000-0003-3304-1645
Eung-Joo LeeUniversity of Arizona, Department of Electrical and Computer Engineering, Tucson, Arizona, United States.
Ali AzhdariniaThe University of Texas Health Science Center at Houston, Houston, Texas, United States.
Sukhen C GhoshThe University of Texas Health Science Center at Houston, Houston, Texas, United States.
Solmaz AghaAmiriThe University of Texas Health Science Center at Houston, Houston, Texas, United States.
Servando Hernandez VargasThe University of Texas Health Science Center at Houston, Houston, Texas, United States.
Naruhiko IkomaThe University of Texas MD Anderson Cancer Center, Houston, Texas, United States.
Jeannelyn EstrellaThe University of Texas MD Anderson Cancer Center, Houston, Texas, United States.
Martin J SchnermannNational Cancer Institute, Center for Cancer Research, Chemical Biology Laboratory, Frederick, Maryland, United States.
Tobias ElseUniversity of Michigan Medical School, Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, Ann Arbor, Michigan, United States.
Michelle Kang KimCleveland Clinic, Department of Gastroenterology, Hepatology, and Nutrition, Cleveland, Ohio, United States.
Juanita L MerchantUniversity of Arizona, College of Medicine, Tucson, Arizona, United States.
Travis W SawyerUniversity of Arizona, Wyant College of Optical Sciences, Tucson, Arizona, United States.ORCID https://orcid.org/0000-0002-6911-0289

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Significance: Pancreatic neuroendocrine neoplasms (PNENs) are an uncommon cancer whose incidence rate has increased dramatically in recent years. Surgery is the only potentially curative treatment, which relies on both preoperative tumor localization and postoperative margin definition using histopathological examination for decision making. If pathology could be automated, valuable time and resources could be saved. Aim: In this study, we investigate the ability of machine learning (ML) with handcrafted features, as well as deep learning, to classify label-free microscopy images of PNENs as a first step toward automated pathology of such tumors. Approach: Patient samples of two different preparation types were imaged, and ML and convolutional neural networks (CNNs) were developed to test the ability of such algorithms to classify PNENs. Results: Our classification algorithms were able to distinguish PNENs from normal tissue with high accuracy using multiphoton microscopy (MPM) images, regardless of sample preparation. Using a combined FFPE and fixed frozen dataset, we achieved an AUC value of 0.793 and an accuracy of 80.6% with ML, and an AUC value of 0.977 and an accuracy of 96.43% using CNNs. Conclusions: Label-free MPM combined with deep learning can provide fast, accurate classification of PNENs. With the ability to assess margins rapidly and potentially automatically, both disease recurrence and the need for resections after initial surgery could be reduced.

Indexed as

artificial intelligencemachine learningmultiphoton microscopypancreatic neuroendocrine neoplasms

Identifiers

PMID42028298
PMCPMC13101064

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.